Table 2.
Results for the primary and secondary outcomes
| Test and groupa | Mean score (standard deviation) |
||
|---|---|---|---|
| Baseline visit | Follow-up visit | Change | |
| Non-OAB AC users | |||
| MMSE | 26.17 (4.71) | 25.26 (5.70) | −1.05 (2.92) |
| CDR | 2.37 (3.54) | 3.21 (4.56) | +0.85 (1.97) |
| Boston name test | 24.48 (6.06) | 24.22 (6.53) | −0.60 (3.05) |
| WAIS-R digit substitution test | 37.80 (16.01) | 36.57 (17.18) | −1.50 (6.61) |
| Trail-making test part B | 133.50 (82.23) | 133.18 (85.78) | 11.10 (52.12) |
| OAB AC users | |||
| MMSE | 26.22 (4.57) | 25.10 (5.93) | −1.24 (3.21) |
| CDR | 2.21 (3.25) | 3.23 (4.43) | +1.02 (2.19) |
| Boston name test | 24.83 (5.44) | 24.34 (6.21) | −0.67 (2.73) |
| WAIS-R digit substitution test | 36.75 (14.83) | 35.76 (15.82) | −1.66 (6.97) |
| Trail-making test part B | 139.73 (84.88) | 142.53 (87.03) | +8.99 (53.50) |
AC = anticholinergic; CDR = Clinical Dementia Rating; MMSE = Mini-Mental Sate Examination; OAB = overactive bladder; WAIS-R = Wechsler Adult Intelligence Scale-revised.
a
Missing data for MMSE (207 individuals), Boston naming test (272 individuals), WAIS-R digit substitution test (694 individuals), and trail-making test part B (489 individuals).